Asunto(s)
Antidepresivos de Segunda Generación/efectos adversos , Erupciones por Medicamentos/etiología , Inhibidores Selectivos de la Recaptación de Serotonina/efectos adversos , Enfermedades Cutáneas Vesiculoampollosas/inducido químicamente , Trazodona/efectos adversos , Anciano de 80 o más Años , Diagnóstico Diferencial , Humanos , Masculino , Pruebas del Parche , Síndrome de Stevens-Johnson/diagnósticoRESUMEN
Background: Lichen planus pemphigoides (LPP), an association between lichen planus and bullous pemphigoid lesions, is a rare subepithelial autoimmune bullous disease. Mucous membrane involvement has been reported previously; however, it has never been specifically studied. Methods: We report on 12 cases of LPP with predominant or exclusive mucous membrane involvement. The diagnosis of LPP was based on the presence of lichenoid infiltrates in histology and immune deposits in the basement membrane zone in direct immunofluorescence and/or immunoelectron microscopy. Our systematic review of the literature, performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, highlights the clinical and immunological characteristics of LPP, with or without mucous membrane involvement. Results: Corticosteroids are the most frequently used treatment, with better outcomes in LPP with skin involvement alone than in that with mucous membrane involvement. Our results suggest that immunomodulators represent an alternative first-line treatment for patients with predominant mucous membrane involvement.